How should I interpret and manage a complete blood count that shows mild normocytic to slightly microcytic anemia (hemoglobin 9.8 g/dL, hematocrit 33.1 %, RBC 3.79 ×10⁶/µL, low MCH and MCHC, elevated RDW) with normal white‑cell differential and marked thrombocytosis (platelets 430 ×10³/µL, increased MPV)?

Laboratory Interpretation: Mild Normocytic Anemia with Thrombocytosis

These labs reveal mild normocytic anemia (Hb 9.8 g/dL, MCV 87 fL) with hypochromia (low MCH 25.9 pg, low MCHC 29.6 g/dL), elevated RDW (16.2%), and reactive thrombocytosis (430 × 10³/µL)—a pattern most consistent with iron deficiency anemia or anemia of chronic disease, requiring immediate iron studies (ferritin, transferrin saturation, serum iron) to guide management.

Primary Abnormalities

Anemia Profile

• Hemoglobin 9.8 g/dL (reference 11.6-15.1): Moderate anemia by WHO criteria, warranting investigation 1
• RBC 3.79 × 10⁶/µL (low): Reduced red cell mass
• Hematocrit 33.1% (low): Proportional to hemoglobin reduction
• MCV 87 fL (normal): Technically normocytic, but the low MCH and MCHC indicate evolving microcytosis
• MCH 25.9 pg (low, reference 26.6-33.5): Hypochromia—red cells contain less hemoglobin
• MCHC 29.6 g/dL (low, reference 32.9-35.4): Confirms hypochromia
• RDW 16.2% (elevated): Indicates anisocytosis—mixed population of red cells

Platelet Abnormalities

• Platelets 430 × 10³/µL (elevated, reference 169-368): Reactive thrombocytosis
• MPV 11.2 fL (elevated): Larger platelets suggest increased turnover

White Cell Parameters

All white cell counts and differentials are normal, making primary bone marrow pathology less likely.

Diagnostic Interpretation

The Pattern Suggests Iron Deficiency

The combination of hypochromia (low MCH/MCHC) with elevated RDW in the setting of anemia is highly characteristic of iron deficiency 1. The British Society of Gastroenterology guidelines emphasize that MCH is actually more reliable than MCV for detecting iron deficiency, as it's less dependent on laboratory variation and is reduced in both absolute and functional iron deficiency 1. Your patient's MCH of 25.9 pg is clearly below the reference range.

The elevated RDW (16.2%) reflects a mixed population of red cells—older normocytic cells produced when iron was adequate, and newer microcytic hypochromic cells produced under iron-deficient conditions. This heterogeneity is a hallmark of evolving iron deficiency 1.

The reactive thrombocytosis (platelets 430) is common in iron deficiency anemia and typically resolves with iron repletion 2. The elevated MPV suggests active platelet production, consistent with a reactive process rather than a primary myeloproliferative disorder.

Alternative Considerations

Anemia of chronic disease can present similarly with normocytic or mildly microcytic indices and low MCH/MCHC 1. However, thrombocytosis would favor iron deficiency over chronic disease, which typically causes normal or low platelet counts.

Thalassemia trait typically shows microcytosis disproportionate to the degree of anemia (MCV often <75 fL with near-normal hemoglobin), elevated RBC count (>5.0 × 10⁶/µL), and normal RDW 3, 4. Your patient's MCV of 87 fL and low RBC count argue against thalassemia.

Sideroblastic anemia would show microcytosis with elevated or normal ferritin and transferrin saturation 3, but this is rare and would require iron studies to exclude.

Immediate Next Steps

1. Order Iron Studies (Mandatory)

You must obtain:

• Serum ferritin: Most specific test for iron deficiency

  • <15 µg/L: Diagnostic of iron deficiency (99% specificity) 1
  • <30 µg/L: Indicates low iron stores 1
  • <45 µg/L: Optimal cutoff balancing sensitivity/specificity (92% specificity) 1

  • 150 µg/L: Excludes absolute iron deficiency even with inflammation 1

• Transferrin saturation (TSAT): Helpful if ferritin is equivocal due to inflammation 1

• Serum iron and TIBC: Support the diagnosis

Critical caveat: Ferritin is an acute phase reactant and can be falsely elevated by inflammation, infection, malignancy, or liver disease 1. If ferritin is 15-150 µg/L in the presence of inflammation (check CRP if available), iron deficiency may still be present.

2. Assess for Blood Loss and Malabsorption

With hemoglobin of 9.8 g/dL in an adult, gastrointestinal investigation is warranted 1:

For men or non-menstruating women:

• The British Society of Gastroenterology recommends investigation at any level of anemia with iron deficiency, with stronger indication when Hb <110 g/L in men or <100 g/L in women 1
• Your patient's Hb of 9.8 g/dL meets criteria for urgent GI evaluation to exclude colorectal cancer, gastric pathology, or celiac disease

For menstruating women:

• Heavy menstrual bleeding is the most common cause
• Still consider GI evaluation if menstrual losses don't fully explain the severity or if alarm symptoms present

Key history points to elicit:

• Melena, hematochezia, hematemesis
• Change in bowel habits
• Abdominal pain, weight loss
• Menstrual history (volume, duration, clots)
• Dietary history (vegetarian/vegan, pica)
• Medications (NSAIDs, anticoagulants, PPIs affecting absorption)
• Family history of GI malignancy or celiac disease

3. Trial of Iron Therapy (Diagnostic and Therapeutic)

A hemoglobin rise ≥10 g/dL within 2 weeks of starting iron therapy is highly suggestive of iron deficiency, even if iron studies are equivocal 1. This therapeutic trial can be both diagnostic and treatment.

Oral iron dosing:

• Ferrous sulfate 200 mg (65 mg elemental iron) once daily on alternate days is as effective as daily dosing with fewer side effects
• Take on empty stomach (or with vitamin C) for optimal absorption
• Avoid with tea, coffee, calcium, or PPIs

Monitor response:

• Recheck CBC in 2 weeks: Expect reticulocytosis and Hb rise
• Recheck at 4-8 weeks: Expect Hb normalization
• Continue iron for 3 months after Hb normalizes to replenish stores

If no response to oral iron: Consider IV iron (malabsorption, intolerance, ongoing losses) or alternative diagnosis.

Common Pitfalls to Avoid

1. Don't assume normocytic MCV excludes iron deficiency: The low MCH and MCHC are more sensitive early markers 1. Your patient is in transition from normocytic to microcytic anemia.

2. Don't skip GI investigation in adults with confirmed IDA: Even if dietary insufficiency seems obvious, occult GI pathology (including malignancy) must be excluded 1.

3. Don't over-interpret the thrombocytosis: Platelets of 430 × 10³/µL with elevated MPV in the setting of anemia is reactive, not a primary myeloproliferative disorder 2. It should normalize with anemia correction.

4. Don't order hemoglobin electrophoresis yet: Reserve this for microcytosis with normal iron studies, particularly in patients of Mediterranean, African, or Southeast Asian descent 1. Your patient's pattern strongly suggests iron deficiency first.

5. Don't ignore inflammation: If ferritin comes back 30-150 µg/L, check CRP. Inflammation can mask iron deficiency by elevating ferritin 1.

Management Algorithm

Mild normocytic anemia + hypochromia (low MCH/MCHC) + elevated RDW + thrombocytosis
                                    ↓
                        Order: Ferritin, TSAT, iron, TIBC
                                    ↓
                    ┌───────────────┴───────────────┐
                    ↓                               ↓
        Ferritin <30 µg/L                  Ferritin 30-150 µg/L
        (Iron deficiency confirmed)         (Check CRP for inflammation)
                    ↓                               ↓
        Start oral iron therapy          If CRP elevated: likely IDA
        Investigate source of loss       If CRP normal: consider alternatives
                    ↓                               ↓
        GI evaluation if:                Start empiric iron trial
        - Men or non-menstruating        Monitor 2-week response
        - Inadequate menstrual           (Hb rise ≥10 g/dL = IDA)
          explanation                              ↓
        - Alarm symptoms                 If no response: IV iron or
                                        reconsider diagnosis